A study of the cerebrospinal fluid in patients with Alzheimer’s disease demonstrated that the activation of the CypA–MMP-9 mechanism is associated with pathological BBB permeability [101]. This evidence concerns the gene MMP9 and early-onset autosomal dominant Alzheimer disease.